Records containing: Tardive Dyskinesia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1065890 in Adult Participants With Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
-
CLINICAL_TRIALS study record update · 2026-04-09Identification, Assessment, and Treatment of Tardive Dyskinesia With Deutetrabenazine in Adults With Intellectual/Developmental Disabilities and Co-occurring Psychiatric and/or Behavioral Disorders
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 4, Single-Arm, Open-Label Study to Evaluate the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Subjects With Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2025-12-05A Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Study on the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation (rTMS) Under Precise Localization for Relieving Motor Symptoms of Tardive Dyskinesia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-19Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
-
CLINICAL_TRIALS study record update · 2025-07-11Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine
-
CLINICAL_TRIALS study record update · 2025-05-01A Feasibility Clinical Trial of the Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for the Management of Treatment-Refractory Movement Disorders
-
CLINICAL_TRIALS study record update · 2024-12-12A Randomized, Double-blind, Placebo-controlled, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 Sustained-release Tablets in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-12-12A Randomized, Open-label, Two-period, Double-crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-10-24Identification, Assessment, and Treatment of Tardive Dyskinesia With Valbenazine in Adults With Intellectual/Developmental Disabilities and Co-occurring Psychiatric and/or Behavioral Disorders
-
CLINICAL_TRIALS study record update · 2024-03-12Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes
-
CLINICAL_TRIALS study record update · 2024-01-29A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 Sustained-release Tablets in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-01-23Examining Engagement Patterns: An Observational Exploration About Tardive Dyskinesia Clinical Trials
-
CLINICAL_TRIALS study record update · 2023-08-14A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Fixed-Dose Study to Evaluate the Efficacy and Safety of MT-5199 for the Treatment in Patients With Tardive Dyskinesia (J-KINECT)
-
CLINICAL_TRIALS study record update · 2023-03-14Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2022-08-24Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive dyskinesia_a Randomized, Double-blind, Sham-controlled Trial
-
CLINICAL_TRIALS study record update · 2021-03-12An Open Label, Proof-of-Principle, Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome
-
CLINICAL_TRIALS study record update · 2021-03-01An Open-Label, Long-Term Safety Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2019-03-22Effect of Varenicline on Smoking Cessation in Patients With Schizophrenia: Evaluation of Antipsychotic Drug-Induced Neurological Symptoms as Correlates of Response
-
CLINICAL_TRIALS study record update · 2019-02-26Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2019-02-15A Randomized, Double-Blind, Placebo-Controlled, Comparative Study to Evaluate the Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia in Patients With Schizophrenia and Schizoaffective Disorders
-
CLINICAL_TRIALS study record update · 2018-12-19Open-Label Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2018-11-30A Phase 3, Open-Label, Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2018-10-11D-SERINE TREATMENT FOR TARDIVE DYSKINESIA